Cleared Traditional

K842225 - HEMODIAL CONCENTRATE MIXING APPARATUS

K842225 is the FDA 510(k) clearance for HEMODIAL CONCENTRATE MIXING APPARATUS by Lmf Medical Research & Manufacturing, Inc.. It is a Class 2 Gastroenterology & Urology device (product code FKQ) cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K842225 · Lmf Medical Research & Manufacturing, Inc. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1984
Decision
119d
Days
Class 2
Risk

K842225 is an FDA 510(k) clearance for the HEMODIAL CONCENTRATE MIXING APPARATUS. Classified as System, Dialysate Delivery, Central Multiple Patient (product code FKQ), Class II - Special Controls.

Submitted by Lmf Medical Research & Manufacturing, Inc. (Mchenry, US). The FDA issued a Cleared decision on October 2, 1984 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5820 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Lmf Medical Research & Manufacturing, Inc. devices

Submission Details

510(k) Number K842225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 1984
Decision Date October 02, 1984
Days to Decision 119 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 130d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FKQ System, Dialysate Delivery, Central Multiple Patient
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FKQ System, Dialysate Delivery, Central Multiple Patient

All 32
Devices cleared under the same product code (FKQ) and FDA review panel - the closest regulatory comparables to K842225.
NEPHROSS ALLEGRO H.F.
K844748 · Organon Teknika Corp. · Jan 1985
ST FAMILY OF HOLLOW FIBER DIALYZERS
K844756 · Travenol Laboratories, S.A. · Jan 1985
DIALYSATE CONCENTRATE FOR HEMODIALYSIS-LIQUID/POWD
K843963 · Renal Systems, Inc. · Jan 1985
PACKETS FOR THE PREP OF DIALYSATES &
K842154 · Organon Teknika Corp. · Jul 1984
CONCENTRATE CONDUCTIVITY METER
K841543 · Renal Systems, Inc. · May 1984
RENAPAK CONCENTRATE MIXING SYS.
K840182 · Renal Systems, Inc. · May 1984